Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Cornell

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
American Journal of Pharmaceutical Education|November 7, 2012
Interprofessional workshop to improve mutual understanding between pharmacy and medical studentsLon J Van Winkle, Bryan C Bjork, Nalini Chandar, et al.
American Journal of Pharmaceutical Education|October 26, 2013
Critical thinking and reflection exercises in a biochemistry course to improve prospective health professions students' attitudes toward physician-pharmacist collaborationLon J Van Winkle, Susan Cornell, Nancy Fjortoft, et al.
The Journal of Organic Chemistry|July 4, 2009
Structural and synthetic investigations of tanikolide dimer, a SIRT2 selective inhibitor, and tanikolide seco-acid from the Madagascar marine cyanobacterium Lyngbya majusculaMarcelino Gutiérrez, Eric H Andrianasolo, Won Kyo Shin, et al.
JACS Au|January 3, 2022
Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple SclerosisChaim Gilon, Michal Klazas, Adi Lahiani, et al.
The Journal of Organic Chemistry|May 10, 2003
Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferaseIvette C Piña, Jeffrey T Gautschi, Gui-Yang-Sheng Wang, et al.
Cancer Cell|July 21, 2004
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathwayAndrew L Kung, Sonya D Zabludoff, Dennis S France, et al.
Journal of Medicinal Chemistry|June 16, 2016
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT InhibitorJean-Marc Lapierre, Sudharshan Eathiraj, David Vensel, et al.
Journal of Medicinal Chemistry|October 3, 2003
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)Stacy W Remiszewski, Lidia C Sambucetti, Kenneth W Bair, et al.
Journal of Medicinal Chemistry|April 27, 2012
Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitorsMark A Ashwell, Jean-Marc Lapierre, Christopher Brassard, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
American Journal of Pharmaceutical Education|November 7, 2012
Interprofessional workshop to improve mutual understanding between pharmacy and medical studentsLon J Van Winkle, Bryan C Bjork, Nalini Chandar, et al.
American Journal of Pharmaceutical Education|October 26, 2013
Critical thinking and reflection exercises in a biochemistry course to improve prospective health professions students' attitudes toward physician-pharmacist collaborationLon J Van Winkle, Susan Cornell, Nancy Fjortoft, et al.
The Journal of Organic Chemistry|July 4, 2009
Structural and synthetic investigations of tanikolide dimer, a SIRT2 selective inhibitor, and tanikolide seco-acid from the Madagascar marine cyanobacterium Lyngbya majusculaMarcelino Gutiérrez, Eric H Andrianasolo, Won Kyo Shin, et al.
JACS Au|January 3, 2022
Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple SclerosisChaim Gilon, Michal Klazas, Adi Lahiani, et al.
The Journal of Organic Chemistry|May 10, 2003
Psammaplins from the sponge Pseudoceratina purpurea: inhibition of both histone deacetylase and DNA methyltransferaseIvette C Piña, Jeffrey T Gautschi, Gui-Yang-Sheng Wang, et al.
Cancer Cell|July 21, 2004
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathwayAndrew L Kung, Sonya D Zabludoff, Dennis S France, et al.
Journal of Medicinal Chemistry|June 16, 2016
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT InhibitorJean-Marc Lapierre, Sudharshan Eathiraj, David Vensel, et al.
Journal of Medicinal Chemistry|October 3, 2003
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)Stacy W Remiszewski, Lidia C Sambucetti, Kenneth W Bair, et al.
Journal of Medicinal Chemistry|April 27, 2012
Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitorsMark A Ashwell, Jean-Marc Lapierre, Christopher Brassard, et al.
Pageof 3